StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Northwest Biotherapeutics's revenue for the twelve months ending Jun 30, 2026 was $2.17M, up 98.6% year over year. For fiscal 2025 it was $1.38M, down 0.3% from the year before. Over ten years it grew -2.3% a year on average. The highest annual figure on record is $2.41M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.38M-0.3%
FY2024Dec 31, 2024$1.38M-28.5%
FY2023Dec 31, 2023$1.93M+14.8%
FY2022Dec 31, 2022$1.68M+67.5%
FY2021Dec 31, 2021$1.01M-22.2%
FY2020Dec 31, 2020$1.29M-46.4%
FY2019Dec 31, 2019$2.41M+485.0%
FY2018Dec 31, 2018$412.00K+22.6%
FY2017Dec 31, 2017$336.00K-46.1%
FY2016Dec 31, 2016$623.00K-64.2%
FY2015Dec 31, 2015$1.74M+19.6%
FY2014Dec 31, 2014$1.45M+79.7%
FY2013Dec 31, 2013$809.00K+4.8%
FY2012Dec 31, 2012$772.00K+7620.0%
FY2011Dec 31, 2011$10.00K0.0%
FY2010Dec 31, 2010$10.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$807.00K+516.0%
Q1 FY2026Mar 31, 2026$494.00K+31.7%
Q4 FY2025Dec 31, 2025$672.00K+190.9%
Q3 FY2025Sep 30, 2025$200.00K-44.0%
Q2 FY2025Jun 30, 2025$131.00K-74.3%
Q1 FY2025Mar 31, 2025$375.00K+32.0%
Q4 FY2024Dec 31, 2024$231.00K-48.1%
Q3 FY2024Sep 30, 2024$357.00K-12.1%
Q2 FY2024Jun 30, 2024$510.00K+153.7%
Q1 FY2024Mar 31, 2024$284.00K-67.7%
Q4 FY2023Dec 31, 2023$445.00K-25.5%
Q3 FY2023Sep 30, 2023$406.00K+97.1%
Q2 FY2023Jun 30, 2023$201.00K-57.9%
Q1 FY2023Mar 31, 2023$880.00K+118.4%
Q4 FY2022Dec 31, 2022$597.00K–
Q3 FY2022Sep 30, 2022$206.00K-41.1%
Q2 FY2022Jun 30, 2022$477.00K-5.2%
Q1 FY2022Mar 31, 2022$403.00K+86.6%
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$350.00K-38.6%
Q4 FY2020Dec 31, 2020$503.00K-43.9%
Q3 FY2020Sep 30, 2020$216.00K-63.6%
Q2 FY2020Jun 30, 2020$2.00K-99.7%
Q1 FY2020Mar 31, 2020$570.00K+68.1%
Q4 FY2019Dec 31, 2019$897.00K+98.0%
Q3 FY2019Sep 30, 2019$593.00K+113.3%
Q2 FY2019Jun 30, 2019$581.00K+340.2%
Q1 FY2019Mar 31, 2019$339.00K+959.4%
Q3 FY2018Sep 30, 2018$453.00K+538.0%
Q2 FY2018Jun 30, 2018$278.00K+74.8%
Q1 FY2018Mar 31, 2018$132.00K-15.9%
Q4 FY2017Dec 31, 2017$32.00K-86.4%
Q4 FY2016Dec 31, 2016$71.00K-91.8%
Q3 FY2016Sep 30, 2016$159.00K–
Q2 FY2016Jun 30, 2016$157.00K–
Q1 FY2016Mar 31, 2016$236.00K–
Q4 FY2015Dec 31, 2015$863.00K–

More Northwest Biotherapeutics figures

See a number that looks wrong?